---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018158"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T13:26:33.392111+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cingulate reports Q1 2024 net loss of $3.0M; CTx-1301 NDA filing on track for 1H 2025

## Summary
- Net loss of $3.0M for Q1 2024, down from $4.0M in Q1 2023.
- Cash and equivalents $1.1M as of March 31, 2024, up from $52K at Dec 31, 2023.
- Raised $10.7M in capital YTD; $3.3M debt converted to equity by Werth Family.
- CTx-1301 NDA filing on track for first half of 2025.
- Stockholders' equity improved to $3.2M from ($6.9M) at year-end 2023.

## SEC filing metadata
- accession: 0001493152-24-018158
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315224018158/0001493152-24-018158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315224018158/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018158
- JSON: https://secwatch.observer/filing/0001493152-24-018158.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018158.txt

## Key facts
- Earnings Releases
  Cingulate Inc. reported for the three months ended March 31, 2024 results: net income Net loss was $3.0 million for the three months ended March 31, 2024, EPS Net loss per share of common stock, basic and diluted $ (0.60 ).
  - Period: for the three months ended March 31, 2024
  - Net income: Net loss was $3.0 million for the three months ended March 31, 2024
  - EPS: Net loss per share of common stock, basic and diluted $ (0.60 )
  - Result: reported results
  source text: On May 8, 2024, Cingulate Inc. issued a press release announcing its financial results for the first quarter of 2024 and providing a clinical and business update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315224018158/0001493152-24-018158-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.